Glaxo and Pfizer Form An HIV Company; Spin-Off Next?
This article was originally published in The Pink Sheet Daily
Executive Summary
Two companies join forces to create a stronger HIV presence than either could mount alone, but the real upside comes if they can spin out the unnamed entity.